Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.9K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K
Stem Cell Culture01:17

Stem Cell Culture

5.3K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.3K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Embryonic Stem Cells00:57

Embryonic Stem Cells

3.7K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.7K
Stem Cell Niche01:26

Stem Cell Niche

5.2K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.2K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression.

Nature communications·2026
Same author

Secretome from Uterine Cervical Mesenchymal Stem Cells as a Protector of Neuronal Cells Against Oxidative Stress and Inflammation.

Biomolecules·2025
Same author

Mesenchymal Stem Cells and Their Derived Products in Ageing and Diseases.

International journal of molecular sciences·2024
Same author

Synergistic effect of human uterine cervical mesenchymal stem cell secretome and paclitaxel on triple negative breast cancer.

Stem cell research & therapy·2024
Same author

Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer.

International journal of molecular sciences·2023
Same author

Towards a New Concept of Regenerative Endodontics Based on Mesenchymal Stem Cell-Derived Secretomes Products.

Bioengineering (Basel, Switzerland)·2023

Related Experiment Video

Updated: Aug 20, 2025

Isolation and Characterization of Mesenchymal Stromal Cells from Human Umbilical Cord and Fetal Placenta
07:06

Isolation and Characterization of Mesenchymal Stromal Cells from Human Umbilical Cord and Fetal Placenta

Published on: April 3, 2017

47.0K

Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies.

Maria Fraile1, Noemi Eiro1, Luis A Costa1

  • 1Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33920 Gijon, Spain.

Biology
|November 24, 2022
PubMed
Summary

Aging causes tissue damage, but mesenchymal stem cells (MSC) can help. A new strategy, Exogenous Restitution of Intercellular Signalling of Stem Cells (ERISSC), uses MSC secretome for anti-aging therapies.

Keywords:
agingconditioned mediumexosomesextracellular vesiclesmesenchymal stem cellssecretometissue homeostasis

More Related Videos

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

1.2K
Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

10.1K

Related Experiment Videos

Last Updated: Aug 20, 2025

Isolation and Characterization of Mesenchymal Stromal Cells from Human Umbilical Cord and Fetal Placenta
07:06

Isolation and Characterization of Mesenchymal Stromal Cells from Human Umbilical Cord and Fetal Placenta

Published on: April 3, 2017

47.0K
Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

1.2K
Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

10.1K

Area of Science:

  • Gerontology and Regenerative Medicine
  • Cellular Biology and Aging Research

Background:

  • Aging involves complex mechanisms like senescence, oxidative stress, and mitochondrial dysfunction, leading to tissue damage and inflamm-aging.
  • Mesenchymal stem cells (MSC) possess multifaceted regenerative properties, including anti-inflammatory and antioxidative effects, crucial for tissue homeostasis.
  • However, MSC themselves are susceptible to aging, limiting their therapeutic efficacy.

Purpose of the Study:

  • To address the limitations of current MSC-based anti-aging strategies.
  • To introduce and explore the potential of Exogenous Restitution of Intercellular Signalling of Stem Cells (ERISSC) as a novel cell-free therapeutic approach.
  • To outline key considerations for developing ERISSC into a viable anti-aging therapy.

Main Methods:

  • Review of existing literature on aging mechanisms and MSC-based therapies.
  • Proposal of the ERISSC strategy utilizing MSC secretome (growth factors, cytokines, extracellular vesicles).
  • Identification of critical research and development aspects for ERISSC implementation.

Main Results:

  • Current MSC-based strategies (senescent cell removal, rejuvenation, replacement) face challenges like adverse drug effects or cell therapy limitations.
  • MSC secretome contains bioactive molecules that mimic the therapeutic effects of parent MSC.
  • ERISSC offers a cell-free alternative with potential to overcome limitations of cell-based therapies.

Conclusions:

  • ERISSC, a cell-free therapy using MSC secretome, presents a promising new strategy for combating aging and frailty.
  • Further research is needed to refine diagnostic tools, optimize MSC selection and secretome production, validate anti-aging effects, and determine optimal administration routes.
  • Successful implementation of ERISSC could revolutionize regenerative medicine and age-related disease treatment.